跳至主要内容
临床试验/NCT07469670
NCT07469670已完成不适用

Nasal Swab Objective and Statistical Evaluation (NOSE Study)

VA Office of Research and Development1 个研究点 分布在 1 个国家目标入组 1,179 人开始时间: 2021年4月5日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
1,179
试验地点
1
主要终点
Sensitivity

研究概览

简要总结

Supply chain disruptions have led to shortages in test swabs which are used to collect respiratory samples. Lack of these test swabs can reduce a hospital or state's ability to test patients for COVID-19.

To address this shortage, many manufacturers, hospitals and individuals have designed non-traditional 3D printed swabs for COVID-19 diagnosis that could potentially meet demands for nasal swabs. However, questions regarding the safety and effectiveness of these swabs remain.

This study will provide additional, statistically supported evidence as to the safety and efficacy of novel swabs.

详细描述

This is a prospective, multi-site, non-inferiority study providing a comparison between the performance of traditional, standard of care (SoC) and alternative (ALT) nasal swabs. Nasal swabs and swabbing site of interest for this study is the nasopharynx (NP swab). The primary outcomes of this study are the rate of adverse events and the agreement in laboratory viral detection between SoC and ALT swabs.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic or COVID-19 positive (within the past 2 weeks)
  • Has a COVID-19 positive household member
  • Female and male Veterans or female and male VHA employees
  • Able and willing to give informed consent

排除标准

  • Self-reported history of frequent nosebleeds or a diagnosis of coagulopathy or any bleeding disorders
  • Unsuitability for mid-turbinate or nasopharyngeal swabbing due to prior surgery
  • Need for legally authorized representative for purpose of giving consent

研究组 & 干预措施

Standard of Care / Standard of Care

Initial cohort to identify the effect of order on swab result. Swab order (standard of care first) was set to preserve clinical test result in case there was an impact to swab order.

1st Alt Swab / Standard of Care

Evaluation of 1st alternatively sourced swab to the standard of care swab

2nd Alt Swab / Standard of Care

Evaluation of 2nd alternatively sourced swab to the standard of care swab

结局指标

主要结局

Sensitivity

时间窗: Day 1

Ability for the alternative swab to correctly predict a positive test result from the standard of care swab (1st swab)

Specificity

时间窗: Day 1

Ability for the alternative swab to correctly predict a negative test result from the standard of care swab (1st swab)

次要结局

  • Epistaxis rate(Day 1)
  • Sensitivity(Day 1)
  • Specificity(Day 1)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验